Personalis at European NeoAG Summit 2019: April 23-25

Sean Michael Boyle, PhD
Director, Bioinformatics Applications
Personalis, Inc.

ImmunoID NeXT Platform: Improving Neoantigen Prediction, TME Assessment, and ctDNA Detection for Vaccine Development

• Innovative genomics methods for more comprehensive assessment of neoantigens
• Improving neoantigen to MHC binding prediction and ranking
• Assessing TME/TCR and tumor escape mechanisms that may impact vaccine response